Advertisement

Topics

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

2017-07-24 12:11:38 | BioPortfolio

Summary

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms similar to HTLV infection.

Description

Post-market, multi-center, study to support a diagnostic sample labeling claim. The Diagnostic Study will assess the performance of the HTLV Blot 2.4 with samples representative of clinical diagnostic samples (HTLV infected and conditions with symptoms similar to that HTLV). This study will use commercially available repository samples from qualified vendors. For neurological specimens not readily available in repository laboratories, prospection collection will be performed to meet the specimen enrollment goals.

Study Design

Conditions

HTLV-I Infections

Intervention

MP Diagnostics HTLV Blot 2.4

Location

LABS, Inc.
Philadelphia
Pennsylvania
United States
19123

Status

Not yet recruiting

Source

MP Biomedicals, LLC

Results (where available)

View Results

Links

Published on BioPortfolio: 2017-07-24T12:11:38-0400

Clinical Trials [282 Associated Clinical Trials listed on BioPortfolio]

Dual Algorithm Post Market Clinical Study

The purpose of this study is to assess the validity and reproducibility of the MP Diagnostics HTLV Blot 2.4 in blood specimens testing repeat reactive (RR) on the first FDA licensed screen...

HTLV-1 Carriers and HTLV-1 Associated Illnesses in Blood Donors in Jamaica

RATIONALE: Collecting information about HTLV-1 carriers and HTLV-1 associated illnesses in blood donors in Jamaica may help doctors learn more about these diseases. PURPOSE: This clinical...

A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)

The objective of this study is to assess the efficacy and safety of KW-0761 after intravenous injections in subjects with HTLV-1 associated myelopathy (HAM) in Japan.

Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)

HTLV-1 Associated Myelopathy is a chronic disease of the spinal cord, caused by a virus called human T lymphotropic virus type 1(HTLV−1). Natural Killer cells provide rapid responses...

Evaluation of InnoLIA HTLV I/II Score

The InnoLIA HTLV I/II Score is an in vitro diagnostic test for confirmation of antibodies to human T-cell lymphotropic virus (HTLV) type I and type II in human blood samples. It is intend...

PubMed Articles [4834 Associated PubMed Articles listed on BioPortfolio]

Evaluation of Line Immunoassay to Detect HTLV-1 Infection in an Endemic Area, Southwestern Japan; Comparison with Polymerase Chain Reaction and Western Blot.

Human T-lymphotropic virus type 1 (HTLV-1) has been recognized as a cause of adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy/tropical spastic paraparesis, and HTLV-1-associated uveitis. H...

Systemic diseases in patients with HTLV-1-associated uveitis.

Human T-lymphotropic virus type 1 (HTLV-1) carriers may develop severe systemic diseases, such as adult T cell leukaemia (ATL) or HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). T...

Turning a blind eye: HTLV-1-associated uveitis in Indigenous adults from Central Australia.

We describe the first two cases of HTLV-1 associated uveitis to be associated with HTLV-1c subtype infection.

Silent dissemination of HTLV-1 in an endemic area of Argentina. Epidemiological and molecular evidence of intrafamilial transmission.

Molecular and epidemiological studies of transmission routes and risk factors for infection by HTLV-1 are extremely important in order to implement control measures, especially because of the high pre...

Ku70 Senses HTLV-1 DNA and Modulates HTLV-1 Replication.

Human T lymphotropic virus type 1 (HTLV-1) belongs to the deltaretrovirus family and has been linked to multiple diseases. However, the innate host defense against HTLV-1 is unclear. In this study, we...

Medical and Biotech [MESH] Definitions

Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED).

Antibodies reactive with the HTLV-I ANTIGENS.

Antibodies reactive with the HTLV-II ANTIGENS.

Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.

Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2.

More From BioPortfolio on "MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study"

Quick Search
Advertisement
 

Searches Linking to this Trial